To determine whether this increase in plasma OPN is dependent on the mice bearing tumors, we treated non–tumor-bearing mice with 5-FU and found no significant difference in OPN levels in the plasma of control mice compared with 5-FU–treated mice (Supplemental Fig. 2F), which suggests that the increase in plasma OPN is dependent on mice bearing tumors. Here, SPP1 is linked to neoplasm.